Lipoperoxidation is selectively involved in progressive supranuclear palsy

Area of Science:

• Neuroscience
• Pathology
• Biochemistry

Background:

• Progressive supranuclear palsy (PSP) is a neurodegenerative disease marked by neurofibrillary tangles (NFTs) and neuronal loss.
• Alzheimer's disease (AD) also features NFTs, with increased advanced glycation end products (AGEs) and oxidation adducts.
• The specific biological events driving PSP pathology remain unclear.

Purpose of the Study:

• To investigate the presence and levels of lipid and protein oxidation markers, and AGEs in midbrain tissue from PSP cases.
• To compare these markers in PSP with sporadic Alzheimer's disease (AD) and age-matched controls.
• To determine the association between lipid peroxidation and neurofibrillary pathology in PSP.

Main Methods:

• Biochemical, immunochemical, and immunocytochemical analyses were performed on midbrain tissue.
• Tissue samples were obtained from 5 PSP cases, 6 AD cases, and 6 controls.
• Levels of 4-hydroxynonenal (HNE), thiobarbituric acid reactive substances (TBARS), pyrraline, pentosidine, and carbonyl groups were measured.

Main Results:

• Lipid peroxidation products, HNE and TBARS, were significantly elevated in PSP compared to controls.
• In AD, only TBARS showed a significant increase, while HNE did not.
• Neuronal HNE immunoreactivity in PSP correlated with the extent of abnormal tau protein.
• Protein oxidation products and AGEs were similar in PSP and control tissues, though AD showed increased AGEs and carbonyls.

Conclusions:

• Lipid peroxidation is selectively associated with neurofibrillary tangle formation in PSP, distinguishing it from AD.
• Intraneuronal accumulation of toxic aldehydes may impede tau degradation, leading to abnormal filament aggregation in PSP.
• These findings highlight a distinct pathological mechanism involving oxidative stress in PSP progression.